Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$13.46 - $48.16 $928,740 - $3.32 Million
-69,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$43.29 - $58.77 $198,701 - $269,754
4,590 Added 7.13%
69,000 $3.18 Million
Q3 2021

Nov 15, 2021

BUY
$36.86 - $54.98 $259,973 - $387,773
7,053 Added 12.3%
64,410 $3.18 Million
Q2 2021

Aug 16, 2021

BUY
$41.49 - $59.92 $876,268 - $1.27 Million
21,120 Added 58.28%
57,357 $2.87 Million
Q1 2021

May 14, 2021

BUY
$46.94 - $58.66 $469,400 - $586,600
10,000 Added 38.11%
36,237 $1.97 Million
Q4 2020

Feb 16, 2021

BUY
$42.51 - $64.0 $535,668 - $806,464
12,601 Added 92.41%
26,237 $1.49 Million
Q3 2020

Nov 13, 2020

BUY
$49.75 - $60.68 $678,391 - $827,432
13,636 New
13,636 $682,000

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $181M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.